These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38779903)

  • 41. A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial.
    Smith K; Pace A; Ortiz S; Kazani S; Rottinghaus S
    Trials; 2020 Jul; 21(1):639. PubMed ID: 32660611
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human and novel coronavirus infections in children: a review.
    Rajapakse N; Dixit D
    Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Masks for Prevention of Respiratory Virus Infections, Including SARS-CoV-2, in Health Care and Community Settings : A Living Rapid Review.
    Chou R; Dana T; Jungbauer R; Weeks C; McDonagh MS
    Ann Intern Med; 2020 Oct; 173(7):542-555. PubMed ID: 32579379
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Myoclonus status revealing COVID 19 infection.
    Ben Mohamed D; Zouari R; Ketata J; Nabli F; Blel S; Ben Sassi S
    Seizure; 2023 Jan; 104():12-14. PubMed ID: 36446232
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19?
    Panigrahy D; Gilligan MM; Huang S; Gartung A; Cortés-Puch I; Sime PJ; Phipps RP; Serhan CN; Hammock BD
    Cancer Metastasis Rev; 2020 Jun; 39(2):337-340. PubMed ID: 32385712
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Selenium and selenoproteins in viral infection with potential relevance to COVID-19.
    Zhang J; Saad R; Taylor EW; Rayman MP
    Redox Biol; 2020 Oct; 37():101715. PubMed ID: 32992282
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Early Th2 inflammation in the upper respiratory mucosa as a predictor of severe COVID-19 and modulation by early treatment with inhaled corticosteroids: a mechanistic analysis.
    Baker JR; Mahdi M; Nicolau DV; Ramakrishnan S; Barnes PJ; Simpson JL; Cass SP; Russell REK; Donnelly LE; Bafadhel M
    Lancet Respir Med; 2022 Jun; 10(6):545-556. PubMed ID: 35397798
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High dose dexamethasone treatment for Acute Respiratory Distress Syndrome secondary to COVID-19: a structured summary of a study protocol for a randomised controlled trial.
    Maskin LP; Olarte GL; Palizas F; Velo AE; Lurbet MF; Bonelli I; Baredes ND; Rodríguez PO
    Trials; 2020 Aug; 21(1):743. PubMed ID: 32843098
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Potential inhibitors of the main protease of SARS-CoV-2 and modulators of arachidonic acid pathway: Non-steroidal anti-inflammatory drugs against COVID-19.
    Sisakht M; Solhjoo A; Mahmoodzadeh A; Fathalipour M; Kabiri M; Sakhteman A
    Comput Biol Med; 2021 Sep; 136():104686. PubMed ID: 34340125
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy and safety of nelfinavir in asymptomatic and mild COVID-19 patients: a structured summary of a study protocol for a multicenter, randomized controlled trial.
    Hosogaya N; Miyazaki T; Fukushige Y; Takemori S; Morimoto S; Yamamoto H; Hori M; Kurokawa T; Kawasaki Y; Hanawa M; Fujii Y; Hanaoka H; Iwami S; Watashi K; Yamagoe S; Miyazaki Y; Wakita T; Izumikawa K; Yanagihara K; Mukae H; Kohno S;
    Trials; 2021 Apr; 22(1):309. PubMed ID: 33910617
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Proteflazid® effectiveness for prevention and treatment of acute viral respiratory infections in the conditions of COVID-19.
    Grynevych O; Borshov S; Matyash V; Momotiuk L; Motuzka O; Yashchenko L
    Pol Merkur Lekarski; 2021 Aug; 49(292):255-265. PubMed ID: 34464364
    [TBL] [Abstract][Full Text] [Related]  

  • 52. COVID-19 and Headache Medicine: A Narrative Review of Non-Steroidal Anti-Inflammatory Drug (NSAID) and Corticosteroid Use.
    Arca KN; Smith JH; Chiang CC; Starling AJ; Robertson CE; Halker Singh RB; Schwedt TJ; Kissoon NR; Garza I; Rozen TD; Boes CJ; Whealy MA; VanderPluym JH
    Headache; 2020 Sep; 60(8):1558-1568. PubMed ID: 32648592
    [TBL] [Abstract][Full Text] [Related]  

  • 53. In Vitro Antiviral and Anti-Inflammatory Activities of
    Marchetti M; De Berardis B; Bigioni I; Mariano A; Superti F; Scotto d'Abusco A
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982205
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Survey of antibiotic and antifungal prescribing in patients with suspected and confirmed COVID-19 in Scottish hospitals.
    Seaton RA; Gibbons CL; Cooper L; Malcolm W; McKinney R; Dundas S; Griffith D; Jeffreys D; Hamilton K; Choo-Kang B; Brittain S; Guthrie D; Sneddon J
    J Infect; 2020 Dec; 81(6):952-960. PubMed ID: 32987097
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Acute Respiratory Infection and Use of Nonsteroidal Anti-Inflammatory Drugs on Risk of Acute Myocardial Infarction: A Nationwide Case-Crossover Study.
    Wen YC; Hsiao FY; Chan KA; Lin ZF; Shen LJ; Fang CC
    J Infect Dis; 2017 Feb; 215(4):503-509. PubMed ID: 28158479
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Non-steroidal anti-inflammatory drugs and clinical outcomes in patients with COVID-19.
    Zhang J; Sheng H; Tang X; Xia P; Li Z; Xu M; Ma J; Shen Y; Yu P; Liu X
    Front Cell Infect Microbiol; 2022; 12():935280. PubMed ID: 36325468
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Non-steroidal anti-inflammatory drugs versus corticosteroids for controlling inflammation after uncomplicated cataract surgery.
    Juthani VV; Clearfield E; Chuck RS
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD010516. PubMed ID: 28670710
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Probiotics: A potential immunomodulator in COVID-19 infection management.
    Singh K; Rao A
    Nutr Res; 2021 Mar; 87():1-12. PubMed ID: 33592454
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Non-steroidal anti-inflammatory drugs for acute gout.
    van Durme CM; Wechalekar MD; Buchbinder R; Schlesinger N; van der Heijde D; Landewé RB
    Cochrane Database Syst Rev; 2014 Sep; (9):CD010120. PubMed ID: 25225849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.